Differential effects of delta9-THC on learning in adolescent and adult rats

Pharmacology, Biochemistry, and Behavior
Young May ChaH Scott Swartzwelder

Abstract

Marijuana use remains strikingly high among young users in the U.S., and yet few studies have assessed the effects of delta9-tetrahydrocannabinol (THC) in adolescents compared to adults. This study measured the effects of THC on male adolescent and adult rats in the Morris water maze. In Experiment 1, adolescent (PD=30-32) and adult (PD=65-70) rats were treated acutely with 5.0 mg/kg THC or vehicle while trained on the spatial version of the water maze on five consecutive days. In Experiment 2, adolescent and adult rats were treated acutely with 2.5 or 10.0 mg/kg THC or vehicle while trained on either the spatial and non-spatial versions of the water maze. In Experiment 3, adolescent and adult rats were treated with 5.0 mg/kg THC or vehicle daily for 21 days, and were trained on the spatial and then the non-spatial versions of the water maze task four weeks later in the absence of THC. THC impaired both spatial and nonspatial learning more in adolescents than in adults at all doses tested. However, there were no long-lasting significant effects on either spatial or non-spatial learning in rats that had been previously exposed to THC for 21 days. This developmental sensitivity is analogous to the effects of ethanol, another comm...Continue Reading

References

Jan 1, 1985·Psychopharmacology·A Stiglick, H Kalant
Jan 1, 1995·Neurotoxicology and Teratology·R C BelueD E Hutchings
Aug 1, 1994·Drug and Alcohol Dependence·C R McLaughlinM E Abood
May 15, 1998·Alcoholism, Clinical and Experimental Research·B J MarkwieseH S Swartzwelder
Apr 20, 1999·Psychopharmacology·H EhrenreichM R Hoehe
Nov 5, 1999·Pharmacology, Biochemistry, and Behavior·F FerrariD Giuliani
May 19, 2000·Neuroscience and Biobehavioral Reviews·L P Spear
Nov 1, 2001·Archives of General Psychiatry·H G PopeD Yurgelun-Todd
Jan 31, 2002·Progress in Neuro-psychopharmacology & Biological Psychiatry·SilvaGeorgeE Da, Reinaldo N Takahashi
Jul 31, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Miriam Schneider, Michael Koch
Jul 15, 2004·Annals of the New York Academy of Sciences·Leslie K JacobsenKenneth R Pugh
Nov 30, 2004·Neuropharmacology·Paola FaddaGernot Riedel

❮ Previous
Next ❯

Citations

Jan 11, 2007·Psychopharmacology·Nicole L Schramm-SapytaCynthia M Kuhn
Jun 24, 2009·Psychopharmacology·Nicole L Schramm-SapytaCynthia M Kuhn
Feb 18, 2011·Psychopharmacology·Nadia SolowijMurat Yücel
Jul 2, 2009·European Archives of Psychiatry and Clinical Neuroscience·Didier Jutras-AswadYasmin L Hurd
Oct 12, 2010·Psychological Medicine·C D SchubartM P M Boks
Aug 19, 2007·Journal of the International Neuropsychological Society : JINS·Krista Lisdahl MedinaSusan F Tapert
May 23, 2012·Journal of the International Neuropsychological Society : JINS·Krista M Lisdahl, Jenessa S Price
Jul 16, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Colm M P O'TuathaighJohn L Waddington
Jan 6, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Christopher D VerricoDavid A Lewis
Sep 1, 2007·Behavioural Pharmacology·Young May ChaHarry Scott Swartzwelder
Aug 5, 2009·Addiction Biology·Krista Lisdahl MedinaSusan F Tapert
Jul 30, 2010·The Journal of Pharmacology and Experimental Therapeutics·Nicole L T MooreCynthia M Kuhn
Nov 6, 2013·Psychopharmacology·Staci A GruberScott E Lukas
Jul 12, 2014·Current Addiction Reports·Krista M LisdahlSkyler Shollenbarger
Mar 15, 2015·Current Addiction Reports·Samuel T WilkinsonDeepak Cyril D'Souza
Sep 23, 2014·Journal of the International Neuropsychological Society : JINS·Jennifer L WinwardSandra A Brown
Sep 12, 2015·Neurotoxicity Research·Patrycja KleczkowskaMagdalena Bujalska-Zadrozny
May 3, 2011·Neuroscience and Biobehavioral Reviews·Paola CasadioMarta Di Forti
Jul 15, 2015·Psychiatry Research·Lucy AlbertellaJan Copeland
Nov 19, 2015·Pharmacology, Biochemistry, and Behavior·Alison G P WakefordAnthony L Riley
Mar 7, 2009·Pharmacology, Biochemistry, and Behavior·Carrie E Wilmouth, Linda P Spear
Dec 30, 2008·Journal of Psychiatric Research·Manzar AshtariSanjiv Kumra
May 10, 2008·Neurotoxicology and Teratology·Diana Dow-Edwards, Ning Zhao
Mar 25, 2008·Molecular and Cellular Endocrinology·T Rubino, D Parolaro
May 1, 2008·Early Intervention in Psychiatry·Dan I Lubman, Murat Yücel
Jan 19, 2010·Drug and Alcohol Review·Eric J Downer, Veronica A Campbell
May 12, 2015·Neuroscience and Biobehavioral Reviews·Alejandro Higuera-MatasEmilio Ambrosio
Apr 8, 2016·Nature Reviews. Neuroscience·H Valerie CurranLoren H Parsons
Apr 17, 2008·European Journal of Pharmacology·Viviana TrezzaLouk J M J Vanderschuren
Sep 10, 2014·Behavioural Brain Research·Martesa TantraHerbert Hildebrandt
Jul 20, 2011·Journal of Psychopharmacology·Tiziana RubinoDaniela Parolaro
Apr 21, 2007·Journal of Psychopharmacology·H R SumnallJ C Cole

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.